Source - SMW
JP Morgan Cazenove today reaffirms its neutral investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1330p (from 1570p).

Related Charts

GlaxoSmithKline (GSK)

-8.00p (-0.61%)
delayed 17:30PM